These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy. Nakamura A; Horinouchi M; Goto M; Nagata K; Sakoda K; Takao S; Imai K; Kim YS; Sato E; Yonezawa S J Pathol; 2002 Jun; 197(2):201-10. PubMed ID: 12015744 [TBL] [Abstract][Full Text] [Related]
4. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Adsay NV; Merati K; Andea A; Sarkar F; Hruban RH; Wilentz RE; Goggins M; Iocobuzio-Donahue C; Longnecker DS; Klimstra DS Mod Pathol; 2002 Oct; 15(10):1087-95. PubMed ID: 12379756 [TBL] [Abstract][Full Text] [Related]
5. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. Utsunomiya T; Yonezawa S; Sakamoto H; Kitamura H; Hokita S; Aiko T; Tanaka S; Irimura T; Kim YS; Sato E Clin Cancer Res; 1998 Nov; 4(11):2605-14. PubMed ID: 9829723 [TBL] [Abstract][Full Text] [Related]
6. Expression of MUC1 and MUC2 mucins in gastric carcinomas: their relationship with clinicopathologic parameters and prognosis. Akyürek N; Akyol G; Dursun A; Yamaç D; Günel N Pathol Res Pract; 2002; 198(10):665-74. PubMed ID: 12498221 [TBL] [Abstract][Full Text] [Related]
7. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors]. Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319 [TBL] [Abstract][Full Text] [Related]
8. [Expression of mucin MUC1 and MUC2 in colorectal carcinoma and their clinical significance]. Huang WB; Shi LH; Zhu XQ; Xu GX; Qi Q Ai Zheng; 2002 Nov; 21(11):1231-4. PubMed ID: 12526222 [TBL] [Abstract][Full Text] [Related]
9. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms. Yonezawa S; Nakamura A; Horinouchi M; Sato E J Hepatobiliary Pancreat Surg; 2002; 9(3):328-41. PubMed ID: 12353144 [TBL] [Abstract][Full Text] [Related]
10. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma. Pinto-de-Sousa J; David L; Reis CA; Gomes R; Silva L; Pimenta A Virchows Arch; 2002 Mar; 440(3):304-10. PubMed ID: 11889602 [TBL] [Abstract][Full Text] [Related]
11. Expression of MUC1 and MUC2 mucin core proteins and their messenger RNA in gall bladder carcinoma: an immunohistochemical and in situ hybridization study. Yamato T; Sasaki M; Watanabe Y; Nakanuma Y J Pathol; 1999 May; 188(1):30-7. PubMed ID: 10398137 [TBL] [Abstract][Full Text] [Related]
12. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma. Higashi M; Yonezawa S; Ho JJ; Tanaka S; Irimura T; Kim YS; Sato E Hepatology; 1999 Dec; 30(6):1347-55. PubMed ID: 10573510 [TBL] [Abstract][Full Text] [Related]
14. Altered mucin core peptide immunoreactivity in the colon polyp-carcinoma sequence. Ho SB; Ewing SL; Montgomery CK; Kim YS Oncol Res; 1996; 8(2):53-61. PubMed ID: 8859775 [TBL] [Abstract][Full Text] [Related]
15. Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren's histologic subtypes of gastric carcinomas. Barresi V; Vitarelli E; Grosso M; Tuccari G; Barresi G Eur J Histochem; 2006; 50(4):301-9. PubMed ID: 17213039 [TBL] [Abstract][Full Text] [Related]
16. Altered MUC1 and MUC2 glycoprotein expression in laryngeal cancer. Jeannon JP; Stafford FW; Soames JV; Wilson JA Otolaryngol Head Neck Surg; 2001 Feb; 124(2):199-202. PubMed ID: 11226957 [TBL] [Abstract][Full Text] [Related]
17. Expression profile of mucins (MUC1, MUC2, MUC5AC, and MUC6) in ovarian mucinous tumours: changes in expression from benign to malignant tumours. Wang J; El-Bahrawy M Histopathology; 2015 Mar; 66(4):529-35. PubMed ID: 25298197 [TBL] [Abstract][Full Text] [Related]
18. Expression of MUC1 in primary and metastatic human epithelial ovarian cancer and its therapeutic significance. Wang L; Ma J; Liu F; Yu Q; Chu G; Perkins AC; Li Y Gynecol Oncol; 2007 Jun; 105(3):695-702. PubMed ID: 17368732 [TBL] [Abstract][Full Text] [Related]
19. MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT). Ueda M; Miura Y; Kunihiro O; Ishikawa T; Ichikawa Y; Endo I; Sekido H; Togo S; Shimada H Hepatogastroenterology; 2005; 52(62):398-403. PubMed ID: 15816444 [TBL] [Abstract][Full Text] [Related]
20. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei. McKenney JK; Soslow RA; Longacre TA Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]